Demethylating agent 5-aza-2′-deoxycytidine activates HLA-G expression in human leukemia cell lines

被引:25
|
作者
Polakova, K. [2 ]
Bandzuchova, E. [3 ]
Kuba, D. [3 ]
Russ, G. [1 ]
机构
[1] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia
[2] Slovak Acad Sci, Canc Res Inst, Bratislava 84505, Slovakia
[3] Slovak Med Univ, Bratislava, Slovakia
关键词
HLA-G; Leukemia cells; Demethylation; 5-Aza-2 '-deoxycytidine; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-CELLS; G GENE; PROMOTER REGION; CANCER; DNA; DECITABINE; INHIBITORS; PROTEINS;
D O I
10.1016/j.leukres.2008.08.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HLA-G is a non-classical HLA class I antigen primarily expressed in the extravillous cytotrophoblast. HLA-G can also be expressed at some pathological circumstances and may thus contribute to inhibition of efficient immune responses. Complex regulation of HLA-G expression also involves epigenetic mechanisms as DNA methylation. Here we demonstrate that treatment with demethylating agent 5-aza-2'-deoxycytidine (AdC) resulted in HLA-G transcription in 18 out of 20 examined leukemia cell lines. FILA-G protein synthesis was detected in 10 cell lines expressing significant level of HLA-G transcripts following AdC treatment. (C) 2008 Elsevier Ltd. All rights reserved
引用
收藏
页码:518 / 524
页数:7
相关论文
共 50 条
  • [21] CELL-DEATH AND CELL-CYCLE PERTURBATION IN THE DEVELOPMENTAL TOXICITY OF THE DEMETHYLATING AGENT, 5-AZA-2'-DEOXYCYTIDINE
    ROGERS, JM
    FRANCIS, BM
    SULIK, KK
    ALLES, AJ
    MASSARO, EJ
    ZUCKER, RM
    ELSTEIN, KH
    ROSEN, MB
    CHERNOFF, N
    TERATOLOGY, 1994, 50 (05) : 332 - 339
  • [22] The Demethylating Agent 5-Aza-2′-Deoxycytidine (5-AZA-CdR) Inhibits The Development of Preimplantation Mouse Embryos
    Yu Jian-Ning
    Li Shao-Hua
    Wang Dan-Qiu
    Wang Meng
    Lin Fen
    Liu Hong-Lin
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2009, 36 (02) : 228 - 237
  • [23] Delineating the effect of demethylating agent 5-aza-2′deoxycytidine on human Caco-2 colonic carcinoma cells
    Li, Xiumei
    Qin, Bingzhao
    Liu, Bo
    ONCOLOGY LETTERS, 2016, 12 (01) : 139 - 143
  • [24] Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines
    Murakami, J
    Asaumi, J
    Maki, Y
    Tsujigiwa, H
    Kuroda, M
    Nagai, N
    Yanagi, Y
    Inoue, T
    Kawasaki, S
    Tanaka, N
    Matsubara, N
    Kishi, K
    ORAL ONCOLOGY, 2004, 40 (06) : 597 - 603
  • [25] Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2'-deoxycytidine
    Zoë L. Vincent
    Murray D. Mitchell
    Anna P. Ponnampalam
    Reproductive Biology and Endocrinology, 13
  • [26] Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2′-deoxycytidine
    Vincent, Zoe L.
    Mitchell, Murray D.
    Ponnampalam, Anna P.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2015, 13
  • [27] Treatment with demethylating agent, 5-aza-2′-deoxycytidine enhances therapeutic HPV DNA vaccine potency
    Lu, Dan
    Hoory, Talia
    Monie, Archana
    Wu, Annie
    Wang, Mei-Cheng
    Hung, Chien-Fu
    VACCINE, 2009, 27 (32) : 4363 - 4369
  • [28] RETRACTED: Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2′-deoxycytidine (Retracted Article)
    Yan, WH
    Lin, AF
    Chang, CC
    Ferrone, S
    CELL RESEARCH, 2005, 15 (07) : 523 - 531
  • [29] Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-aza-2′-deoxycytidine
    Arai, Makoto
    Yokosuka, Osamu
    Hirasawa, Yuichi
    Fukai, Kenichi
    Chiba, Tetsuhiro
    Imazeki, Furnio
    Kanda, Tatsuo
    Yatomi, Mari
    Takiguchi, Yuichi
    Seki, Naohiko
    Saisho, Hiromitsu
    Ochiai, Takenori
    CANCER, 2006, 106 (11) : 2514 - 2525
  • [30] Demethylating agent 5-aza-2′-deoxycytidine enhances expression of TNFRI and promotes TNF-mediated apoptosis in vitro and in vivo
    Kaminski, R
    Kozar, K
    Niderla, J
    Grzela, T
    Wilczynski, G
    Skierski, JS
    Koronkiewicz, M
    Jakobisiak, M
    Golab, J
    ONCOLOGY REPORTS, 2004, 12 (03) : 509 - 516